RH genotype matching for transfusion support in sickle cell disease

Blood

Volumn 132, Issue 11, 2018, Pages 1198-1207

  Chou, Stella T ^a   Evans, Perry ^a   Vege, Sunitha ^b   Coleman, Sarita L ^a   Friedman, David F ^a   Keller, Margaret ^c   Westhoff, Connie M ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NEW YORK BLOOD CENTER   (United States)

^c American Red Cross   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; RHESUS ANTIBODY; RHCE PROTEIN, HUMAN; RHO(D) ANTIGEN;

AFRICAN AMERICAN; ALLOIMMUNIZATION; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP TYPING; BLOOD TRANSFUSION; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; ALLELE; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION REACTION; CAUCASIAN; FEMALE; GENETICS; MALE;

AFRICAN AMERICANS; ALLELES; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; RH-HR BLOOD-GROUP SYSTEM; TRANSFUSION REACTION;

EID: 85053121551     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2018-05-851360     Document Type: Article

References (23)

1. Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood. 2013;122(6): 1062-1071.
2. Reid ME, Halter Hipsky C, Hue-Roye K, Hoppe C. Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease. Blood Cells Mol Dis. 2014;52(4): 195-202.
3. Yazer MH, Delaney M, Germain M, et al; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Trends in US minority red blood cell unit donations. Transfusion. 2017;57(5):1226-1234.
4. Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014; 312(10):1033-1048.
5. Wilkinson K, Harris S, Gaur P, et al. Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease. Transfusion. 2012;52(2): 381-388.
6. Lane WJ, Westhoff CM, Uy JM, et al; MedSeq Project. Comprehensive red
7. blood cell and platelet antigen prediction from whole genome sequencing: proof of principle. Transfusion. 2016;56(3): 743-754.
8. Chou ST, Flanagan JM, Vege S, et al. Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv. 2017;1(18): 1414-1422.
9. Westhoff CM, Vege S, Hipsky CH, et al. RHCE*ceAG (254C.G, Ala85Gly) is prevalent in blacks, encodes a partial ce-phenotype, and is associated with discordant RHD zygosity. Transfusion. 2015;55(11):2624-2632.
10. Chiu RW, Murphy MF, Fidler C, Zee BC, Wainscoat JS, Lo YM. Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach. Clin Chem. 2001;47(4): 667-672.
11. Reid ME, Lomas-Francis C, Olsson ML. The Blood Group Antigen Facts Book. 3rd ed. San Diego, CA: Elsevier Academic Press; 2012.
12. Yazer MH, Vassallo R, Delaney M, et al; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Trends in age and red blood cell donation habits among several racial/ethnic minority groups in the United States. Transfusion. 2017;57(7):1644-1655.
13. Lasalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion. 2011;51(8):1732-1739.
14. Tahhan HR, Holbrook CT, Braddy LR, Brewer LD, Christie JD. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion. 1994;34(7):562-569.
15. Karafin MS, Field JJ, Gottschall JL, Denomme GA. Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease. Transfusion. 2015;55(6 Pt 2):1399-1406.
16. Issitt PD, Anstee DJ. Applied Blood Group Serology. 4th ed: Durham, NC: Montgomery Scientific Publications; 1998.
17. Flegel WA, Wagner FF, Chen Q, et al. The RHCE allele ceCF: the molecular basis of Crawford (RH43). Transfusion. 2006;46(8): 1334-1342.
18. Wagner FF, Ladewig B, Flegel WA. The RHCE allele ceRT: D epitope 6 expression does not require D-specific amino acids. Transfusion. 2003;43(9):1248-1254.
19. Vege S, Lomas-Francis C, Hu Z, Hue-Roye K, Patel P, Westhoff CM. E antigen typing discrepancy reveals a novel 674C.G change (Ser225Cys) on RhCe responsible for expression of some E epitopes [abstract]. Transfusion 2012:52S. Abstract S54-030I.
20. Yazer MH, Jackson B, Beckman N, et al; Biomedical Excellence for Safer Transfusions (BEST) Collaborative. Changes in blood center red blood cell distributions in the era of patient blood management: the trends for collection (TFC) study. Transfusion. 2016;56(8): 1965-1973.
21. Flegel WA, Gottschall JL, Denomme GA. Integration of red cell genotyping into the blood supply chain: a population-based study. Lancet Haematol. 2015;2(7):e282-e289.
22. Sesok-Pizzini DA, Friedman DF, Smith-Whitley K, Nance SJ. Transfusion support of patients with sickle cell disease at the Children’s Hospital of Philadelphia. Immunohematology. 2006;22(3):121-125.
23. Frye V, Caltabiano M, Kessler DA, et al. Evaluating a program to increase blood donation among racial and ethnic minority communities in New York City. Transfusion. 2014;54(12):3061-3067.